Content about Anxiety disorder

July 30, 2012
Mental health, medicines 
top of mind for industry

In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.


In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.


The Pharmaceutical Research and Manufacturers of America released a report listing 187 drugs, including 52 for depression, 37 for schizophrenia and 26 for anxiety disorders.


March 22, 2012
Teva launches generic Lexapro, awarded 180-day exclusivity

Teva Pharmaceutical Industries Ltd. announced on March 14 that it has commenced commercial launch of escitalopram oxalate tablets, the company’s generic version of Forest Laboratories’ depression and generalized anxiety disorder treatment Lexapro tablets.

Teva Pharmaceutical Industries Ltd. announced on March 14 that it has commenced commercial launch of escitalopram oxalate tablets, the company’s generic version of Forest Laboratories’ depression and generalized anxiety disorder treatment Lexapro tablets.

The branded product had annual sales of approximately $2.9 billion in the United States, based on IMS sales data. As the first company to file an abbreviated new drug application containing a paragraph IV certification for this product, Teva has been awarded a 180-day period of marketing exclusivity.

March 14, 2012
FDA approves generic version of Lexapro

The Food and Drug Administration has approved the first generic version of an antidepressant made by Forest Labs, the agency said Wednesday.

SILVER SPRINGS, Md. — The Food and Drug Administration has approved the first generic version of an antidepressant made by Forest Labs, the agency said Wednesday.

The FDA announced the approval of a generic version of Lexapro (escitalopram) made by Teva Pharmaceutical Industries in the 5-mg, 10-mg and 20-mg strengths. The drug is used to treat depression and generalized anxiety disorder in adults.

February 29, 2012
Mylan launches generic version of Forest Labs' Lexapro

Mylan has launched a generic drug for treating depression and anxiety, the company said Wednesday.

PITTSBURGH — Mylan has launched a generic drug for treating depression and anxiety, the company said Wednesday.

Mylan announced the launch of escitalopram tablets in the 5-mg, 10-mg and 20-mg strengths, the first generic version of Forest Labs' Lexapro. The drug is used for treating major depressive disorder and generalized anxiety disorder.

May 20, 2011
Mood disorders may be precursor to diabetes in Latinos, study finds

Such mood disorders as anxiety and depression may be a precursor to diabetes in Latinos, according to a study by University of California at San Diego researchers scheduled for presentation at the American Psychiatric Association’s annual meeting in Honolulu.

NEW YORK — Such mood disorders as anxiety and depression may be a precursor to diabetes in Latinos, according to a study by University of California at San Diego researchers scheduled for presentation at the American Psychiatric Association’s annual meeting in Honolulu.

As reported in the Los Angeles Times, the researchers found that while Latinos have higher-than-average rates of diabetes, they also seem to have higher-than-average risk of having both diabetes and a mood disorder.